Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Varenicline for Smoking Cessation in Bipolar Depressed Patients: An Open-Label 12-week Feasibility Trial

NCT00813800 is registered in ClinicalTrials.gov with Mark Frye as lead sponsor.

NCT NCT00813800
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00813800 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Varenicline for Smoking Cessation in Bipolar Depressed Patients: An Open-Label 12-week Feasibility Trial
Lead sponsor
Mark Frye
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2009
Completion date
February 28, 2011
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder, depression, smoking